title: [18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study.
authors.affiliation: Nuklearmedizin, Universitätskliniken, Ulm, Germany. buchmann@nuklear.klinik.uni-mainz.de
authors.forename: Inga
authors.initials: I
authors.lastname: Buchmann
authors.forename: Bernd
authors.initials: B
authors.lastname: Neumaier
authors.forename: Mathias
authors.initials: M
authors.lastname: Schreckenberger
authors.forename: Sven
authors.initials: S
authors.lastname: Reske
mesh_terms: D000328:Adult; D000368:Aged; D015224:Dideoxynucleosides / Q000493:pharmacokinetics; D005260:Female; D005462:Fluorine Radioisotopes; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics
chemical_list: D015224:Dideoxynucleosides; D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; C002854:alovudine